Literature DB >> 9143094

Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA).

M C Cornel1, J D Erickson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143094     DOI: 10.1002/(SICI)1096-9926(199702)55:2<134::AID-TERA3>3.0.CO;2-3

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


× No keyword cloud information.
  7 in total

1.  Impact of misclassification of in vitro fertilisation in studies of folic acid and twinning: modelling using population based Swedish vital records.

Authors:  R J Berry; R Kihlberg; O Devine
Journal:  BMJ       Date:  2005-02-18

Review 2.  Prevention of myelomeningocele: African perspectives.

Authors:  Taopheeq Bamidele Rabiu; Amos Olufemi Adeleye
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

Review 3.  Folate and epigenetic mechanisms in neural tube development and defects.

Authors:  Sivan Vadakkadath Meethal; Kirk J Hogan; Chandra S Mayanil; Bermans J Iskandar
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

4.  Simultaneous folate intake may prevent adverse effect of valproic acid on neurulating nervous system.

Authors:  Ahmet Sukru Umur; Mehmet Selcuki; Adem Bursali; Nurcan Umur; Burcu Kara; H Seda Vatansever; Yusuf Kurtulus Duransoy
Journal:  Childs Nerv Syst       Date:  2012-01-14       Impact factor: 1.475

5.  Methylmalonic acid in amniotic fluid and maternal urine as a marker for neural tube defects.

Authors:  Xiaoping Luo; Lian Zhang; Hong Wei; Wanjun Liu; Muti Wang; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

6.  Do multivitamin supplements reduce the risk for congenital heart defects? Evidence and gaps.

Authors:  L Botto
Journal:  Images Paediatr Cardiol       Date:  2000-10

Review 7.  Preconception care: nutritional risks and interventions.

Authors:  Sohni V Dean; Zohra S Lassi; Ayesha M Imam; Zulfiqar A Bhutta
Journal:  Reprod Health       Date:  2014-09-26       Impact factor: 3.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.